Access cutting-edge hepatitis c treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Access hepatitis c specialists in Cincinnati at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatitis c treatment provided free
This is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or third trimester in approximately 100 pregnant people. Maternal participants will take one SOF/VEL tablet once daily for 12 weeks (84 days) and followed until 12 weeks after treatment completion (postpartum). Infants will be followed from birth until one year of age. The primary objectives are to evaluate the
Sponsor: Catherine Anne Chappell
Check if you qualify for this hepatitis c clinical trial in Cincinnati, OH
If you're searching for hepatitis c treatment options in Cincinnati, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatitis c specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.